Skip to main content
Caplight Logo









Axo Longevity

Axo Longevity

Private
—Healthcare & Life Scienceshttps://www.axolongevity.com/

Last Round

Seed

Sep 15, 2026

Total Funding Raised

$5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

-

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Subscription Commerce, Healthcare Analytics, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

longevity platformbiomarker testinghuman performance platformpersonalized health planhealth optimizationwellness subscriptionbiological age calculationbiohackingD2C healthproactive healthprecision wellnessAI copilotquantified selfAI health coachhealthspan optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axo Longevity Comparables

Compare Axo Longevity with similar companies based on industry and business-model similarity.

No public comparables are available for Axo Longevity. Request access to learn about comparables coverage.

Request access

Axo Longevity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 15, 2026

Key People

Founding team and executive leadership

Andrew McCarthy

Founder And CEO

Founding Team

Axo Longevity Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2026

    $5M round with participation from MS&AD Ventures and NIAN Sports & Entertainment.

Axo Longevity Filings

Explore SEC and related filing metadata, where available.

Axo Longevity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Axo Longevity's valuation, stock price, and market status.

Is Axo Longevity a public or private company?

Axo Longevity is a private company.

What is the current stock price of Axo Longevity?

Axo Longevity is a private company with no public stock price. Caplight tracks Axo Longevity's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Axo Longevity worth (valuation)?

Valuation information for Axo Longevity is not publicly available.

Can I buy Axo Longevity stock?

Axo Longevity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Axo Longevity's last funding round?

Axo Longevity's most recent funding round was Seed on September 15, 2026.

Who are the main investors in Axo Longevity?

Key investors in Axo Longevity include MS&AD Ventures, Izou Partners, 51Ventures, LifeX Ventures, UNQ Coinvestments Group.

Will Axo Longevity IPO soon?

No public IPO plans have been announced for Axo Longevity.

How can I track Axo Longevity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axo Longevity's secondary market activity and sign up for updates.

Firmographic Details

Headquarters—
Year FoundedN/A
Last FundingSep 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?